Polycythaemia Vera (PV) is a myeloproliferative disorder in which bone marrow has increased production of red blood cells, white blood cells and platelets. The hallmarks of the disease are veno-occlusive events, secondary to increased blood viscosity. Polycythaemia Vera rarely presents with portal vein thrombosis below age of 55 years especially in absence of any chronic liver disease. We report a case of 30-years-old South Asian male presenting with abdominal pain, weight loss and vomiting for 3 months. On evaluation, he was found to have oesophageal varices. Furthermore, CT scan showed infiltration at porta-hepatis and portal venous thrombosis. Polycythaemia Vera was diagnosed with a positive JAK2 mutation and increased haemoglobin. Lapar...
In some patients presenting with complications of portal hypertension, thrombosis of hepatic or port...
Polycythemia vera (PV) is a clonal Ph-negative myeloproliferative disorder characterized by excessiv...
In patients who do not meet the World Health Organization (WHO) criteria for overt polycythaemia ver...
Polycythaemia Vera (PV) is a myeloproliferative disorder in which bone marrow has increased producti...
Polyglobulia is secondary polycythaemia commonly due to underlying non haematological diseases like ...
Portal vein thrombosis (PVT) is an uncommon finding in patients without cirrhosis. The underlying x\...
Budd-Chiari syndrome may be defined as a heterogeneous group of vascular disorders characterized by ...
Portal vein thrombosis is an uncommon finding that typically arises in the context of cirrhosis. In ...
Background: Oesophageal varices and gastrointestinal bleeding are common complications of liver cirr...
Portal vein thrombosis (PVT) is a rare finding which usually occurs in association with local factor...
A patient who presented with severe abdominal pain was found to have an intrahepatic haematoma com-p...
Essential thrombocythemia is a myeloproliferative disorder characterized by an elevated platelet cou...
In patients who do not meet the World Health Organization (WHO) criteria for overt polycythaemia ver...
Portal vein thrombosis (PVT) is a rare disorder that is associated with a variety of underlying cond...
In some patients presenting with complications of portal hypertension, thrombosis of hepatic or port...
In some patients presenting with complications of portal hypertension, thrombosis of hepatic or port...
Polycythemia vera (PV) is a clonal Ph-negative myeloproliferative disorder characterized by excessiv...
In patients who do not meet the World Health Organization (WHO) criteria for overt polycythaemia ver...
Polycythaemia Vera (PV) is a myeloproliferative disorder in which bone marrow has increased producti...
Polyglobulia is secondary polycythaemia commonly due to underlying non haematological diseases like ...
Portal vein thrombosis (PVT) is an uncommon finding in patients without cirrhosis. The underlying x\...
Budd-Chiari syndrome may be defined as a heterogeneous group of vascular disorders characterized by ...
Portal vein thrombosis is an uncommon finding that typically arises in the context of cirrhosis. In ...
Background: Oesophageal varices and gastrointestinal bleeding are common complications of liver cirr...
Portal vein thrombosis (PVT) is a rare finding which usually occurs in association with local factor...
A patient who presented with severe abdominal pain was found to have an intrahepatic haematoma com-p...
Essential thrombocythemia is a myeloproliferative disorder characterized by an elevated platelet cou...
In patients who do not meet the World Health Organization (WHO) criteria for overt polycythaemia ver...
Portal vein thrombosis (PVT) is a rare disorder that is associated with a variety of underlying cond...
In some patients presenting with complications of portal hypertension, thrombosis of hepatic or port...
In some patients presenting with complications of portal hypertension, thrombosis of hepatic or port...
Polycythemia vera (PV) is a clonal Ph-negative myeloproliferative disorder characterized by excessiv...
In patients who do not meet the World Health Organization (WHO) criteria for overt polycythaemia ver...